Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

GT Biopharma, Inc. (GTBP) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

GT Biopharma, Inc. (GTBP), most recent 12 months reported: net loss $4.76M. Latest balance sheet on file: liquid cash $6.81M. From SEC filings. Others in Pharmaceutical Preparations: GEOVAX LABS, INC. · Structure Therapeutics Inc. · Grace Therapeutics, Inc. · GRI BIO, INC. · Hepion Pharmaceuticals, Inc. · WEREWOLF THERAPEUTICS, INC. · TuHURA BIOSCIENCES, INC./NV · IMMIX BIOPHARMA, INC.

Stock screener

Watchlist